Study of Metatinib Tromethamine Tablet

NCT02650375 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced or Metastatic Gastric Cancer
Advanced or Metastatic Liver Cancer
Advanced or Metastatic CRC
Advanced or Metastatic Non Squamous NSCLC

Interventions

DRUG: Metatinib Tromethamine

Sponsor

Jiangsu Simcere Pharmaceutical Co., Ltd.